Funded Tech Companies
CRISPR Therapeutics
Headquartered in Cambridge, CRISPR Therapeutics raised its funding from Bayer, Vertex Pharmaceuticals and New Leaf Venture Partners.
Company Overview
Company Name
CRISPR Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
610 Main St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
The mission of CRISPR Therapeutics (Nasdaq: CRSP) is to develop transformative gene-based medicines for patients with serious diseases. Our therapeutic approach is to cure diseases at the molecular level using the breakthrough gene editing technology called CRISPR-Cas9.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/18/2016
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Samarth Kulkarni
President
Rodger Novak
VP - Bus. Development
Lawrence Klein
VP - General Counsel
James Kasinger
VP - Human Resources
Megan Menner
VP - R & D
Tony Ho
Company Investors
- Bayer
- Vertex Pharmaceuticals
- New Leaf Venture Partners
- Wellington Management Company
- Clough Capital Partners
- Franklin Templeton
- SR One Capital Management (Simeon George)
- Celgene
- New Enterprise Associates (Ali Behbahani)
- Abingworth (Kurt von Emster)
- Versant Ventures (Brad Bolzon)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs